Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2025 Jun 19;19(1):307.
doi: 10.1007/s11701-025-02476-1.

Robotic thymectomy for large thymomas: a multicenter study

Dania Nachira #  1 , Maria Teresa Congedo #  2 , Luca Bertolaccini  3 , Pierluigi Novellis  4   5 , Pietro Bertoglio  6 , Angela De Palma  7 , Rosalia Romano  8 , Federico Raveglia  9 , Khrystyna Kuzmych  2 , Alessia Senatore  2 , Matteo Chiari  3   10 , Sebastiano Maiorca  3   10 , Cinzia Scala  4   5 , Matteo Petroncini  6 , Debora Brascia  11 , Graziana Carleo  7 , Francesca Spinelli  9 , Francesco Petrella  9 , Filippo Lococo  2 , Diego Gavezzoli  8 , Jury Brandolini  6 , Giuseppe Marulli  11 , Giulia Veronesi  4   5 , Lorenzo Spaggiari  3   10 , Stefano Margaritora #  2 , Elisa Meacci #  2
Affiliations
Observational Study

Robotic thymectomy for large thymomas: a multicenter study

Dania Nachira et al. J Robot Surg. .

Erratum in

  • Correction: Robotic thymectomy for large thymomas: a multicenter study.
    Nachira D, Congedo MT, Bertolaccini L, Novellis P, Bertoglio P, De Palma A, Romano R, Raveglia F, Kuzmych K, Senatore A, Chiari M, Maiorca S, Scala C, Petroncini M, Brascia D, Carleo G, Spinelli F, Petrella F, Lococo F, Gavezzoli D, Solli P, Brandolini J, Marulli G, Veronesi G, Spaggiari L, Margaritora S, Meacci E. Nachira D, et al. J Robot Surg. 2025 Aug 25;19(1):508. doi: 10.1007/s11701-025-02684-9. J Robot Surg. 2025. PMID: 40853577 No abstract available.

Abstract

This study aimed to evaluate surgical and oncological outcomes of robot-assisted (RATS) thymectomy in the treatment of large (diameter > = 5 cm) resectable thymomas. Clinical data of 301 thymectomies for thymoma, performed in 7 high-volume centers from 2010 to 2023, were retrospectively reviewed. 132 RATS thymectomies were performed: 59 (44.7%) for small and 73 (55.3%) for large thymomas. Conversion (p = 0.48), significant complications (p = 0.26), and hospital stay (p = 0.79) were similar in both groups. Overall, 191 large thymomas were operated on: 73(38.2%) by RATS, 118 (61.8%) by open approach. Comparing the RATS approach with the open standard approach for the treatment of large thymomas, more post-operative complications (p < 0.001) but similar major complications (p = 0.11) and a longer in-hospital stay (p < 0.001) were recorded in the open group. Five-year OS (95% vs 85%, p = 0.14) and DFS (86 vs 93%, p = 0.18) of patients affected by large thymomas were comparable between RATS and the open group. To minimize selection-confounding factors between the two large thymoma groups (RATS vs open) in relation to the outcomes, a 1:1 propensity score match (PSM) analysis was performed, and surgical and oncological outcomes reassessed. Chest tube length (p < 0.001) and in-hospital stay (p < 0.001) were confirmed to be longer in the open group. Prognostic factors for oncological outcomes for large thymomas were also confirmed after PSM analysis. Adjuvant radiotherapy was the only predictive factor (p = 0.033) affecting DFS, while no factor was confirmed for OS at multivariable analysis. RATS seems to be a safe and effective alternative to open surgery for treating large thymomas.

Keywords: Large thymomas; Outcomes; RATS; Thymectomy.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: Pierluigi Novellis has received a lecture fee from Abmedica and a travel grand from Medtronic.The other authors declare no conflict of interest. Ethical approval: The present study was approved by the Ethics Committee (Università Cattolica del Sacro Cuore) on 19 January 2020 (Approval Code: 2020/8903) and therefore conducted in accordance with the ethical standards of the Declaration of Helsinki and its later amendments. Informed consent: Informed consent was obtained from all subjects involved in the study.

References

    1. Regnard JF, Magdeleinat P, Dromer C, Dulmet E, de Montpreville V, Levi JF et al (1996) Prognostic factors and longterm results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg 112:376–384 - PubMed
    1. Detterbeck FC, Parsons AM (2011) Management of stage I and II thymoma. Thorac Surg Clin 21(1):59–67 - PubMed
    1. Margaritora S, Cesario A, Cusumano G et al (2010) Thirty-five-year follow-up analysis of clinical and pathologic outcomes of thymoma surgery. Ann Thorac Surg. 89(1):245–52 - PubMed
    1. Petroncini M, Solli P, Brandolini J, Lai G, Antonacci F, Garelli E et al (2023) Early postoperative results after thymectomy for thymic cancer: a single-institution experience. World J Surg. 47(8):1978–1985 - PubMed - PMC
    1. Girard Ruffini E, Marx A, Faivre-Finn C, Peters S (2015) on behalf of the ESMO guidelines committeethymic epithelial tumours:ESMO clinical practice guidelines for diagnosis, treatment and follow-up. N Annal Oncol 26(5):40–55

Publication types

MeSH terms

LinkOut - more resources